Vaccination contre le méningocoque B
- PMID: 39622535
- PMCID: PMC11611383
- DOI: 10.1503/cmaj.231807-f
Vaccination contre le méningocoque B
Conflict of interest statement
Intérêts concurrents :: Jasmine Hasselback est membre du comité de la Saskatchewan sur l’immunisation. Aucun autre intérêt concurrent n’a été déclaré.
References
-
- Pham-Huy A, Zafack J, Primeau C, et al. . Deeks S on behalf of the National Advisory Committee on Immunization. A National Advisory Committee on Immunization (NACI) update on invasive meningococcal disease (IMD) epidemiology and program-relevant considerations for preventing IMD in individuals at high risk of exposure. Can Commun Dis Rep 2023;49:358–67. - PMC - PubMed
-
- Invasive meningococcal disease. Ottawa: Public Health Agency of Canada; 2023. Accessible ici : https://www.canada.ca/en/public-health/services/immunization/vaccine-pre... (consulté le 10 sept. 2023).
-
- Canadian immunization guide: meningococcal vaccines. Ottawa: Public Health Agency of Canada; 2023. Accessible ici : https://www.canada.ca/en/public-health/services/publications/healthy-liv... (consulté le 10 sept. 2023).
-
- Meningococcal B vaccines. Immunize.org; 2023. Accessible ici : https://www.immunize.org/askexperts/experts_meningococcal_b.asp#precautions (consulté le 10 sept. 2023).
-
- Summary of updates of National Advisory Committee on Immunization advice on invasive meningococcal disease in the Canadian Communicable Disease Report: le 25 sept. 2023. Ottawa: Public Health Agency of Canada; 2023. Accessible ici : https://www.canada.ca/en/public-health/services/publications/vaccines-im... (consulté le 24 févr. 2024).
LinkOut - more resources
Full Text Sources
Medical